|
1
|
Burns DJ and Quantz MA: Use of the impella
5.0 device as a bridge to recovery in adult fulminant viral
myocarditis. Innovations Phila. 10:279–281. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sharma M, Mishra B, Saikia UN, Bahl A,
Ratho RK and Talwar KK: Role of coxsackie virus and adenovirus
receptor (CAR) expression and viral load of adenovirus and
enterovirus in patients with dilated cardiomyopathy. Arch Virol.
19:102–103. 2015.
|
|
3
|
Valaperti A: Drugs targeting the canonical
NF-κB pathway to treat viral and autoimmune myocarditis. Curr Pharm
Des. 22:440–449. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Xu HF, Meng L, Yao J, Gu ZY, Liu GQ, Shen
YW and Zhao ZQ: Myocardial expression of Spry1 and MAPK proteins of
viral myocarditis. Fa Yi Xue Za Zhi. 29:164–167. 2013.(In Chinese).
PubMed/NCBI
|
|
5
|
Ma XL, Kumar S, Gao F, Louden CS, Lopez
BL, Christopher TA, Wang C, Lee JC, Feuerstein GZ and Yue TL:
Inhibition of p38 mitogen-activated protein kinase decreases
cardiomyocyte apoptosis and improves cardiac function after
myocardial ischemia and reperfusion. Circulation. 99:1685–1691.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sun S, Ma J, Zhang Q, Wang Q, Zhou L, Bai
F, Hu H, Chang P, Yu J and Gao B: Argonaute proteins in cardiac
tissue contribute to the heart injury during viral myocarditis.
Cardiovasc Pathol. 25:120–126. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huber SA: Viral myocarditis and dilated
cardiomyopathy: etiology and pathogenesis. Curr Pharm Des.
22:408–426. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Su N, Yue Y and Xiong S: Monocytic
myeloid-derived suppressor cells from females, but not males,
alleviate CVB3-induced myocarditis by increasing regulatory and
CD4(+)IL-10(+) T cells. Sci Rep. 6:226582016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhu H, Lou C and Liu P: Interleukin-27
ameliorates coxsackie virus B3-induced viral myocarditis by
inhibiting Th17 cells. Virol J. 12:1892015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shi Y, Chen C, Lisewski U, Wrackmeyer U,
Radke M, Westermann D, Sauter M, Tschope C, Poller W, Klingel K and
Gotthardt M: Cardiac deletion of the Coxsackievirus-adenovirus
receptor abolishes Coxsackievirus B3 infection and prevents
myocarditis in vivo. J Am Coll Cardiol. 53:1219–1226. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tomko RP, Xu R and Philipson L: HCAR and
MCAR: the human and mouse cellular receptors for subgroup C
adenoviruses and group B coxsackie viruses. Proc Natl Acad Sci USA.
94:3352–3356. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xu HF, Chen JL, Da XP, Wu KR, Liu GQ, Zhao
ZQ and Han XH: Expression of CAR in myocardial of viral myocarditis
and dilated cardiomyopathy. Fa Yi Xue Za Zhi. 26:328–331. 2010.(In
Chinese). PubMed/NCBI
|
|
13
|
Fischer R, Poller W, Schultheiss HP and
Gotthardt M: CAR-diology - a virus receptor in the healthy and
diseased heart. J Mol Med Berl. 87:879–884. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shi Y, Chen C, Lisewski U, Wrackmeyer U,
Radke M, Westermann D, Sauter M, Tschöpe C, Poller W, Klingel K, et
al: Cardiac deletion of the coxsackie virus-adenovirus receptor
abolishes coxsackie virus B3 infection and prevents myocarditis in
vivo. J Am Coll Cardiol. 53:1219–1226. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ballard-Croft C, White DJ, Maass DL, Hybki
DP and Horton JW: Role of p38 mitogen-activated protein kinase in
cardiac myocyte secretion of the inflammatory cytokine TNF-alpha.
Am J Physiol Heart Circ Physiol. 280:1970–1981. 2001.
|
|
16
|
Wang M, Sankula R, Tsai BM, Meldrum KK,
Turrentine M, March KL, Brown JW, Dinarello CA and Meldrum DR: P38
MAPK mediates myocardial proinflammatory cytokine production and
endotoxin-induced contractile suppression. Shock. 21:170–174. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Henke A, Launhardt H, Klement K, Stelzner
A, Zell R and Munder T: Apoptosis in coxsackievirus B3-caused
diseases: interaction between the capsid protein VP2 and the
proapoptotic protein siva. J Virol. 74:4284–4290. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sreekanth GP, Chuncharunee A,
Sirimontaporn A, Panaampon J, Noisakran S, Yenchitsomanus PT and
Limjindaporn T: SB203580 modulates p38 MAPK signaling and dengue
virus-induced liver injury by reducing MAPKAPK2, HSP27, and ATF2
phosphorylation. PLoS One. 11:e01494862016. View Article : Google Scholar : PubMed/NCBI
|
